We subsequently demonstrated that AD4-GHPE has tumor-specific cytotoxicity and enhances CD8+ T-cell immune responses by reducing PD-L1 expression in breast and hypopharyngeal cancer PDOs. This evidence concerns the gene PSEN2 and neoplasm.